VISCO, VALERIA
 Distribuzione geografica
Continente #
AS - Asia 5.583
NA - Nord America 1.573
EU - Europa 1.017
SA - Sud America 241
AF - Africa 46
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.464
Nazione #
HK - Hong Kong 4.362
US - Stati Uniti d'America 1.502
SG - Singapore 592
IT - Italia 534
CN - Cina 200
BR - Brasile 184
VN - Vietnam 157
RU - Federazione Russa 155
BD - Bangladesh 87
DE - Germania 87
FR - Francia 47
IN - India 46
CA - Canada 40
GB - Regno Unito 36
KR - Corea 25
JP - Giappone 23
NL - Olanda 23
SE - Svezia 23
AT - Austria 20
FI - Finlandia 20
ES - Italia 19
AR - Argentina 18
MX - Messico 16
IQ - Iraq 15
IE - Irlanda 14
PL - Polonia 14
TR - Turchia 13
EC - Ecuador 12
ZA - Sudafrica 12
ID - Indonesia 9
VE - Venezuela 8
CO - Colombia 7
KE - Kenya 6
PK - Pakistan 6
SA - Arabia Saudita 6
EG - Egitto 5
IR - Iran 5
JO - Giordania 5
PH - Filippine 5
TN - Tunisia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
JM - Giamaica 4
LT - Lituania 4
MA - Marocco 4
AL - Albania 3
AU - Australia 3
CZ - Repubblica Ceca 3
IL - Israele 3
NI - Nicaragua 3
NP - Nepal 3
PY - Paraguay 3
RO - Romania 3
BO - Bolivia 2
CH - Svizzera 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
LB - Libano 2
MY - Malesia 2
NG - Nigeria 2
UA - Ucraina 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.464
Città #
Hong Kong 4.359
Singapore 308
San Jose 293
Dallas 185
Ashburn 178
Milan 170
Beijing 58
Council Bluffs 58
New York 56
Chandler 49
Ho Chi Minh City 49
Rome 49
Naples 45
Los Angeles 40
Munich 40
Hanoi 39
The Dalles 39
Lauterbourg 38
Princeton 34
Fisciano 29
Moscow 29
Santa Clara 29
Nuremberg 24
São Paulo 23
Memphis 22
Tokyo 22
Salerno 20
Denver 19
Stockholm 19
Ann Arbor 18
Domicella 18
Orem 18
Frankfurt am Main 17
Boardman 15
Montreal 15
Dublin 13
Turku 13
Brooklyn 12
Buffalo 12
San Francisco 12
Seoul 12
Warsaw 12
Amsterdam 11
London 11
Turin 11
Atlanta 10
Houston 10
Chicago 9
Da Nang 9
Phoenix 9
Sarno 9
Seattle 9
Charlotte 8
Chennai 8
Figino 8
Vienna 8
Belo Horizonte 7
Biên Hòa 7
Haiphong 7
Querétaro 7
Manchester 6
Montoro 6
Washington 6
West Jordan 6
Ankara 5
Bari 5
Bengaluru 5
Boston 5
City of London 5
Guangzhou 5
Helsinki 5
Nairobi 5
Norwalk 5
Poplar 5
Tashkent 5
Toronto 5
Amman 4
Baghdad 4
Caracas 4
Jacksonville 4
Jeddah 4
Johannesburg 4
Milwaukee 4
Mumbai 4
Shanghai 4
Tehran 4
Wilmington 4
Zelarino 4
Afragola 3
Andover 3
Brasília 3
Cairo 3
Calgary 3
Canoas 3
Cardito 3
Cleveland 3
Curitiba 3
Feira de Santana 3
Goiânia 3
Greensboro 3
Totale 6.836
Nome #
589 THE EFFECT OF DAPAGLIFLOZIN ON SYMPTOMS, QUALITY OF LIFE AND ECHOCARDIOGRAPHIC PARAMETERS IN A REAL-WORLD POPULATION OF HFREF PATIENTS 902
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control 892
Cardiovascular Implications of microRNAs in Coronavirus Disease 2019 706
Plasma miR-1-3p levels predict severity in hospitalized COVID- 19 patients 581
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 475
Sacubitril/Valsartan vs. Standard Medical Therapy on Exercise Capacity in HFrEF Patients 269
Technological Developments, Exercise Training Programs, and Clinical Outcomes in Cardiac Telerehabilitation in the Last Ten Years: A Systematic Review 264
Retrospective Study on Short-Term Reverse Cardiac Remodeling in Obese Patients Undergoing Sleeve Gastrectomy 261
Serum uric acid and left ventricular mass in essential hypertension 256
Cardiovascular Nursing in Rehabilitative Cardiology: A Review 227
The favourable alliance between cardiomems and levosimendan in patients with advanced heart failure 225
Vitamin D, parathyroid hormone and cardiovascular risk: The good, the bad and the ugly 222
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 181
An explainable model for predicting Worsening Heart Failure based on genetic programming 161
719 CIRCULATING SORTILIN LEVELS ARE INCREASED IN PATIENTS RECEIVING LONG-TERM WARFARIN AND ITS INHIBITION ATTENUATES WARFARIN-INDUCED VASCULAR CALCIFICATION 145
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 129
A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS 121
C2CD4B Evokes Oxidative Stress and Vascular Dysfunction via a PI3K/Akt/PKCα–Signaling Pathway 118
Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work 115
Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview 109
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function 108
Artificial intelligence as a business partner in cardiovascular precision medicine: An emerging approach for disease detection and treatment optimization 107
We are What We Eat: Impact of Food from Short Supply Chain on Metabolic Syndrome 99
A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm®) and Anthocyanins Exerts Beneficial Cardiovascular Effects 92
Epigenetic mechanisms underlying the beneficial effects of cardiac rehabilitation. An overview from the working groups of “cellular and molecular biology of the heart” and “cardiac rehabilitation and cardiovascular prevention” of the Italian Society of Cardiology (SIC) 89
The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers 87
Vitamin D: A Bridge between Kidney and Heart. 86
Serum parathormone, vitamin D and cardiovascular risk factors and markers: A pilot study 84
Artificial intelligence in cardiovascular prevention: new ways will open new doors 83
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function 82
Exercise Echocardiography of Left Ventricular Diastolic Function in Healthy Subjects: Insights From the RIGHT-NET 80
Frail hypertensive older adults with prediabetes and chronic kidney disease: insights on organ damage and cognitive performance - preliminary results from the CARYATID study 76
Larger Blood Pressure Reduction by Fixed-Dose Compared to Free Dose Combination Therapy of ACE Inhibitor and Calcium Antagonist in Hypertensive Patients 76
The metabolic role of grk2 in insulin resistance and associated conditions 76
The role of oxidative stress in cardiovascular aging and cardiovascular diseases 75
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better 71
Aortic Remodeling in Patients with Arterial Hypertension: Pathophysiological Mechanisms, Therapeutic Interventions and Preventive Strategies—A Position Paper from the Heart and Hypertension Working Group of the Italian Society of Hypertension 69
It is easy to see, but it is better to foresee: a case report on the favourable alliance between CardioMEMS and levosimendan 68
Subclinical left ventricular dysfunction assessed by global longitudinal strain correlates with mild cognitive impairment in hypertensive patients 63
Accuracy of home blood pressure measurement: the ACCURAPRESS study - a proposal of Young Investigator Group of the Italian Hypertension Society (Societa Italiana dell'Ipertensione Arteriosa) 61
Endothelial microRNAs in INOCA patients with diabetes mellitus 58
Vericiguat in heart failure with reduced ejection fraction: hope or solid reality? 54
Prediabetes Increases the Risk of Frailty in Prefrail Older Adults With Hypertension: Beneficial Effects of Metformin 53
SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug? 53
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 52
GRK2 and Mitochondrial Dynamics in Cardiovascular Health and Disease 51
Mitochondrial accumulation of GRK2 as a protective mechanism against hypoxia-induced endothelial dysfunction 50
Plasma miR-1-3p levels predict severity in hospitalized COVID-19 patients 47
Evaluation of the Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure: Design and Rationale of the TELEREHAB-HF Study 41
Lung ultrasound in cardiac rehabilitation: expert consensus on protocols, clinical use, and integration into patient management from the working group on cardiac rehabilitation and cardiovascular prevention of the Italian society of cardiology 37
Unraveling the risk factors for type II diabetes in severe obese patients with indication for bariatric Surgery: retrospective analysis 29
Analysis of a Real-World Population Participating in a Cardiac Rehabilitation Program: Cognitive Impairment, Functional Capacity, and Therapy Titration 18
Artificial intelligence-based remote monitoring for chronic heart failure: design and rationale of the SMART-CARE study 17
Totale 8.551
Categoria #
all - tutte 19.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202255 0 0 0 0 0 0 14 3 4 3 6 25
2022/2023118 9 18 8 13 15 18 0 12 15 1 6 3
2023/2024214 6 15 13 11 21 26 16 8 4 12 9 73
2024/2025793 9 15 14 50 56 78 180 47 118 27 93 106
2025/20267.186 1.327 2.124 1.317 260 379 180 388 107 251 332 166 355
2026/2027121 121 0 0 0 0 0 0 0 0 0 0 0
Totale 8.551